AsparlasActive Ingredient(s): Calaspargase Pegol-mknl
FDA Approved: * December 20, 2018
Pharm Company: * SERVIER PHARMA LLC
Calaspargase pegol, sold under the brand name Asparlas, is a medication for the treatment of acute lymphoblastic leukemia (ALL). It is approved in the United States as a component of a multi-agent chemotherapeutic regimen for ALL in pediatric and young adult patients aged one month to 21 years. Calaspargase pegol is an engineered protein consisting of the E. coli-derived enzyme L-asparaginase II conjugated with succinimidyl carbonate monomethoxypolyethylene glycol (pegol).... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Asparlas 750 U/Ml Intravenous Injection, SolutionNDC: 72694-515
Servier Pharmaceuticals LLC